Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Panacea Biotec financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

₹133.2

2024-07-03

Market Capitalization

₹8.3 B

2024-07-03

Revenue

₹4.6 B

FY, 2023

CreditSafe Score

?
Score changed on Jul 22, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023
Revenue5.7B4.5B5.4B6.2B6.6B4.6B
Cost of goods sold2.1B2.0B1.7B2.3B3.0B2.8B
Gross profit3.9B2.6B3.7B4.0B3.7B1.9B
Gross profit margin, %57.7%69.4%64.8%55.5%40.6%
Operating expense total2.9B3.7B3.1B3.1B3.7B2.8B
Depreciation and amortization585.3M540.0M441.4M500.7M444.4M391.2M
EBITDA995.3M(1.1B)808.6M901.6M(52.0M)(652.2M)
EBITDA margin, %-24.6%15.1%14.6%-0.8%-14.3%
EBIT386.1M1.7B213.3M400.9M16.3B(16.8M)
EBIT margin, %37.3%4.0%6.5%246.7%-0.4%
Interest income11.7M6.8M47.9M32.7M33.9M115.6M
Interest expense1.0B1.0B1.7B1.9B1.8B44.4M
Pre tax profit(661.4M)486.2M(1.8B)(1.5B)14.5B128.1M
Income tax expense98.6M77.1M169.5M26.3M3.7B465.5M
Net Income(760.0M)409.1M(1.9B)(1.5B)10.8B(337.4M)

Footer menu